$169.182,00
10% de descuento pagando con Transferencia
Ver más detalles
Descripcion
Indice
Autores
Muestra
Ficha Técnica
Descripción

This issue brings the rheumatologist on the current thinking on treatment of Systemic Lupus Erythematosus, with an eye to the future. Topics covered include B cell biology and related therapies; glutamate receptor biology and its clinical significance in neuropsychiatric SLE; platelet C4d and vascular complications; biomarkers in lupus nephritis; endothelial function and its implications for cardiovascular and renal disease in SLE; changing worldwide epidemiology of SLE and its relationship to environmental, ethnic, and other sociodemographic factors; work loss, disability, quality of life, and compliance in SLE; pediatric lupus; metabolic syndrome and related endocrine abnormalities; the significance of interferon and the consequences of anti-interferon in SLE; and cutaneous lupus and the CLASI instrument.

1. Cover - p. 1 2. Contributors - p. 2 3. Contents - p. 3 4. Forthcoming Issues - p. 4 5. Preface - p. 5 6. Changing Worldwide Epidemiology of Systemic Lupus Erythematosus - p. 6 7. Health-Related Quality of Life and Employment Among Persons with Systemic Lupus Erythematosus - p. 12 8. Cutaneous Lupus and the Cutaneous Lupus Erythematosus Disease Area and Severity Index Instrument - p. 20 9. Pediatric Lupus—Are There Differences in Presentation, Genetics, Response to Therapy, and Damage Accrual Compared with Adult Lupus? - p. 30 10. The Metabolic Syndrome in Systemic Lupus Erythematosus - p. 43 11. Gonadal Failure with Cyclophosphamide Therapy for Lupus Nephritis: Advances in Fertility Preservation - p. 52 12. B-cell Biology and Related Therapies in Systemic Lupus Erythematosus - p. 59 13. Biomarkers in Lupus Nephritis - p. 71 14. Endothelial Function and its Implications for Cardiovascular and Renal Disease in Systemic Lupus Erythematosus - p. 78 15. Cell-Bound Complement Biomarkers for Systemic Lupus Erythematosus: From Benchtop to Bedside - p. 88 16. Interferon-alpha: A Therapeutic Target in Systemic Lupus Erythematosus - p. 94 17. Glutamate Receptor Biology and its Clinical Significance in Neuropsychiatric Systemic Lupus Erythematosus - p. 101 18. Index - p. 110

Descripcion
Descripción

This issue brings the rheumatologist on the current thinking on treatment of Systemic Lupus Erythematosus, with an eye to the future. Topics covered include B cell biology and related therapies; glutamate receptor biology and its clinical significance in neuropsychiatric SLE; platelet C4d and vascular complications; biomarkers in lupus nephritis; endothelial function and its implications for cardiovascular and renal disease in SLE; changing worldwide epidemiology of SLE and its relationship to environmental, ethnic, and other sociodemographic factors; work loss, disability, quality of life, and compliance in SLE; pediatric lupus; metabolic syndrome and related endocrine abnormalities; the significance of interferon and the consequences of anti-interferon in SLE; and cutaneous lupus and the CLASI instrument.

1. Cover - p. 1 2. Contributors - p. 2 3. Contents - p. 3 4. Forthcoming Issues - p. 4 5. Preface - p. 5 6. Changing Worldwide Epidemiology of Systemic Lupus Erythematosus - p. 6 7. Health-Related Quality of Life and Employment Among Persons with Systemic Lupus Erythematosus - p. 12 8. Cutaneous Lupus and the Cutaneous Lupus Erythematosus Disease Area and Severity Index Instrument - p. 20 9. Pediatric Lupus—Are There Differences in Presentation, Genetics, Response to Therapy, and Damage Accrual Compared with Adult Lupus? - p. 30 10. The Metabolic Syndrome in Systemic Lupus Erythematosus - p. 43 11. Gonadal Failure with Cyclophosphamide Therapy for Lupus Nephritis: Advances in Fertility Preservation - p. 52 12. B-cell Biology and Related Therapies in Systemic Lupus Erythematosus - p. 59 13. Biomarkers in Lupus Nephritis - p. 71 14. Endothelial Function and its Implications for Cardiovascular and Renal Disease in Systemic Lupus Erythematosus - p. 78 15. Cell-Bound Complement Biomarkers for Systemic Lupus Erythematosus: From Benchtop to Bedside - p. 88 16. Interferon-alpha: A Therapeutic Target in Systemic Lupus Erythematosus - p. 94 17. Glutamate Receptor Biology and its Clinical Significance in Neuropsychiatric Systemic Lupus Erythematosus - p. 101 18. Index - p. 110

Indice
Autores
Muestra
Ficha Técnica